Clinical Trial Update: Improvement of Quality of Life by Cannabinoids in Oncologic Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating whether cannabinoids can improve quality of life in cancer patients and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Cannabinoids (cannabinoids)

Snippet

Sponsor: University Hospital Schleswig-Holstein | Conditions: Medical Oncology, Palliative Care | Phase 2 | Status: RECRUITING